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SUMMARY
Noroviruses are an important cause of acute gastroenteritis in humans. We incorporated new
insights gained over the past decade in an updated estimate of the disease burden of (foodborne)
norovirus illness in The Netherlands in 2009. The disease outcomes – non-consulting cases,
visiting a general practitioner, hospitalization and mortality – and the foodborne proportion were
derived from cohort studies, surveillance data and literature. Age-specific incidence estimates were
applied to the population age distribution in The Netherlands in 2009. The general population
incidence was 3800/100 000 (95% CI 2670–5460), including 0.4 fatal cases/100 000, resulting in
1622/100 000 (95% CI 966–2650) disability-adjusted life-years in a population of 16.5 million.
The updated burden of norovirus is over twofold higher than previously estimated, due in
particular to the new insights in case-fatality ratios. Results suggest that the burden of norovirus
institutional outbreaks is relatively small compared to the burden of community-acquired
norovirus infections.
Key words: Foodborne infections, gastroenteritis, incidence, Norwalk agent and related viruses,
surveillance.
INTRODUCTION
Noroviruses are responsible for a large number of
infections worldwide each year. Noroviruses are
highly infectious [1], environmentally stable [2], and
able to utilize different transmission routes. Trans-
mission can occur from person to person, after
ingestion of contaminated food or water, or through
contact with contaminated surfaces or aerosols [3].
Several prospective population-based studies were
performed, e.g. in the UK and The Netherlands, re-
sulting in estimates of norovirus gastroenteritis inci-
dence of 1/80 to 1/64 of the population per annum in
the UK between 1993 and 1996 [4] and 1/18 to 1/26 in
2008–2009 [5], and 1/31 inhabitants in The Nether-
lands in 1999 (Sensor) [6]. The annual burden of
norovirus in The Netherlands was estimated to be
450 disability-adjusted life-years (DALYs) with an
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incidence of 2900/100 000 (470 000 cases/year), cost-
ing Dutch society 25 million euros in 2004 [7]. Es-
timating the incidence or burden due to solely
foodborne norovirus transmission is difficult due to
the entanglement of transmission modes ; after food-
borne introduction, person-to-person transmission
quickly takes over.
The initial burden estimates did not include
institutional norovirus outbreaks for which epidemi-
ological and health impacts may be different [8].
Moreover, at the time of the Sensor study, norovirus
infection was considered a mild and self-limiting dis-
ease with a low case-fatality ratio (CFR) [9]. Over the
past decade, significant progress has been made in
the field of norovirus research, yielding new knowl-
edge about the virus and its health outcomes. For
example, recent studies revealed that significant mor-
tality may be associated with norovirus infections,
particularly in the elderly [10, 11]. Newly emer-
ging variants have been recognized every 2 years since
2002, causing epidemics across Europe and world-
wide [12] corresponding with an increase in the
number of norovirus outbreaks [13] and increased
mortality [10].
Given the changes and new insights obtained
over the last decade, there is a need for an updated
burden estimate for norovirus infections. Our objec-
tive is to determine the disease burden of norovirus
illness in The Netherlands in 2009 and its estimated
foodborne proportion, while including the newly de-
rived knowledge of the past decade.
METHODS
Our starting point was the burden estimate for The
Netherlands 2004 [7], using methods and updates de-
scribed elsewhere [14, 15].
Disease outcomes
The disease outcomes following infection were defined
by designing an outcome tree, in which each block
represents a health outcome, while between blocks
transition probabilities must be established (Fig. 1).
Input parameters
The studies described in literature that provided data
for our input parameters are listed in Table 1. Details
of the data used are given in annex 2 of Havelaar
et al. [15].
Burden estimate
The different outcomes of (infectious) disease can
be combined in one single metric, the DALY, fol-
lowing the methodology described previously [14],
with a DALY being the sum of years of life lost (YLL)
and the number of years lived with disability (YLD).
Community-acquired acute gastroenteritis
Age-specific incidence rates of community-acquired
gastroenteritis attributed to norovirus as well as the

















Fig. 1. Outcome tree for norovirus-associated gastroenteritis.
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Table 1. Overview of studies providing data for the calculation of norovirus burden in The Netherlands
Factor Population Measure Period Study design Ref.




1999–2006 Syndromic surveillance [10]
Mandatory reporting norovirus General German population Case-based data including
mortality
Since 2001 Mandatory reporting [19]
Hospitalization due to
community-acquired norovirus
Dutch hospitalized children aged








Prospective in six hospitals [18]
Friesema et al. (unpublished data)
Community-acquired
sporadic GE due to
norovirus
General Dutch population Incidence of overall GE and
proportion of norovirus




Outbreaks of GE in
The Netherlands
General Dutch population Number of GE outbreaks Jan.–Dec. 2002 Intensified surveillance [23]
Gastroenteritis
surveillance systems
General Dutch population Hospital diagnosis of GE Since 2002 Surveillance [17]
Outbreaks of viral GE in
The Netherlands




Since 1995 Routine laboratory surveillance [22]
Risk factors of norovirus
infection
General Dutch population that
tested positive in
population-based study




Life expectancy of the
elderly in long-term care
facilities
Long-term care patients in
Dublin hospital
Mean and median survival,
risk factors, death






























(GP) were estimated using methodology described
elsewhere [14, 15], using data from a nested case-
control study within the 1999 population-based
study Sensor [16]. Information on the percentage of
patients visiting their GP for a norovirus infection
was derived from a nested case-control study within
the Sensor study [16]. These estimates were applied to
the population age distribution in The Netherlands in
2009, as derived from Statistics Netherlands (www.
cbs.nl). Incidence estimates were updated from 1999 to
2009 with a trend correction of 125%, as derived from
trends in hospitalizations for viral gastroenteritis by
all causes collected in the Dutch National Disease
Registry for hospitalization (Prismant) with a national
coverage of 88% [17]. According to this registry,
21 932 persons were admitted to hospital for gastro-
enteritis in 2009, 38% of them were children (aged
<18 years). Data on aetiology were obtained from the
GastroEnteritis Admission Study (Dutch acronym:
GEops) [18]. Briefly, patients admitted to six hospitals
for gastroenteritis during the period May 2008–
November 2009 were included in the study. Ninety-six
faecal samples from children and 41 samples from
adults (aged o18 years) were analysed for pathogens
by multiplex PCR (eight bacteria and five viruses) or
microscopy (six parasites). At least one pathogen was
detected in 98% of samples from children and 59%
of samples from adults. Co-infections (two or more
pathogens in one sample) were detected in 40% and
22% of samples from children and adults, respect-
ively. The fraction of hospitalized cases due to acute
gastroenteritis attributable to norovirus (fG), was
modelled as a beta distribution also accounting for
mixed infections (e.g. attributing the infection for half





where G=number of samples tested for presence or
absence of norovirus in GEops; posG(j)=number of
samples from which norovirus was isolated as (j=1)
the only pathogen; (j=2) with one other pathogen;
(j=3) with two other pathogens; w(j)=weight
[w(1)=1; w(2)=1/2; w(3)=1/3] ; beta(a, b)=prior
distribution for fG ; in this case an informed prior
distribution beta(0.15, 4) was used.
Mortality due to norovirus was derived from
Germany’s electronic surveillance system of infectious
diseases, in which norovirus infection is statutorily
notifiable [19] and thereby one of the few systems,
if not the only, in Europe providing case-fatality
ratios for all age groups. Local health departments
follow-up each notification and complete a case-
report that is transmitted, via state health depart-
ments, to the Robert Koch-Institute. Each case-form
has a field for ‘death’, which should be marked if the
death of the notified person is ‘causally related’ to the
infection or where this, according to the information
of the local health department, cannot be excluded.
Age group-specific CFRs were derived from this sur-
veillance system using the age categorization of the
Sensor study, and applied to the age-specific estimates
of community-acquired gastroenteritis attributed to
norovirus in The Netherlands in 2009. An informed
prior distribution beta(0.15, 4) was used. We adopted
the life expectancy derived from the standard model
life table (West model 25 and 26 for males and fe-
males), as recommended by WHO [20]. Disability
weights were derived from a Dutch population panel,
using elicitation protocols as described by Haagsma
et al. [21], and presented in Table 2.
Institutional outbreaks
The numbers of outbreaks in nursing homes, hospi-
tals and other institutional settings were derived from
passive laboratory-based surveillance on outbreaks
reported to the RIVM in 2009 [22]. The mean number
of cases involved in outbreaks in these settings was
derived from a 1-year intensified outbreak surveil-
lance study in The Netherlands in 2002 [23], while
assuming that the proportion of patients visiting a GP
is comparable to that in community-acquired cases.
The incidence of fatal cases in institutional outbreaks
(i.e. in nursing homes, hospitals and other institu-
tional settings) was based on the case-fatality ratio for
people aged o65 years as derived from Germany’s
electronic surveillance system. For fatal cases living in
institutions, a life-expectancy of 30 months was used,
as described by Cunningham et al. [24], to account for
comorbidity. Disability weights representative of per-
sons living in nursing homes were not available, and
may differ from the elderly living in the community
due to underlying illness and quality of life. There-
fore, the disability weight of living in an institution
was assumed to be in the middle between the dis-
ability weight of hospital admission and visiting a GP.
Discounting
Disease burden is presented both undiscounted
and discounted at a rate of 1.5% as currently re-
commended in The Netherlands [25].
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Burden of foodborne disease
Community acquired
The proportion of norovirus cases attributed to food
was based on expert elicitation [26], i.e. food safety
experts were asked to provide their estimates of the
most likely range for each of the parameters, and joint
probability distributions were created by probabilistic
inversion.
Outbreaks
The proportion of outbreaks attributed to food was
derived from previous analyses of the Foodborne
Viruses in Europe (FBVE) network’s database [27].
Statistical analysis
A stochastic Monte Carlo simulation model was
built to quantify the uncertainty in the disease burden
of norovirus-associated illness, using @RISK 5.0
(Palisade Decision Tools, USA), a Monte Carlo
simulation add-in for Excel 2002 (Microsoft, USA).
The model was run for 10 000 iterations. The distri-
bution functions of parameters that were used to
estimate the disease burden of infection with noro-
virus are described elsewhere [15], and estimates based
on new data are shown in Tables 3–5. The sensitivity
of model outcomes in relation to uncertain input
parameters were analysed using regression analyses
using the Tornado Plot function in @RISK. Other




The estimates for age-specific CFRs are presented in
Table 3, clearly showing the highest CFR for people
aged o65 years. The data of hospital admissions due
to norovirus in children and adults are presented in
Table 4.





(/1000)* (95% CI) (/1000)*
Mean beta
distribution (/1000)#
0 0.09 0.09 (0.0136–0.2728) 0.10%
1–4 0.00 0.00 (0–0.01727) 0.00%
5–11 0.00 0.00 (0–0.04244) 0.01%
12–17 0.07 0.09 (0.0037–0.3397) 0.10%
18–64 0.03 0.03 (0.0121–0.0625) 0.03%
o65 0.63 0.63 (0.5453–0.7287) 0.63%
CI, Confidence interval.
* CFRs on the basis of the German surveillance system
# CFRs estimated for the Dutch population using an informed prior distribution beta(0.15, 4).








Not visiting GP 0.000 – [21]
Visiting GP 0.015 1 [21]
Hospitalized 0.041 1 [21]
Institutional outbreaks
Death 1 2.5 (2–3.3) [24]
Nursing homes 0.028 1
Hospitals 0.028 1
GP, General practitioner.
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Outbreaks
The data of outbreaks in nursing homes and other
settings are presented in Table 5, showing a total of
132 laboratory-reported outbreaks involving 4650
cases in The Netherlands in 2009.
Burden of disease
Community-acquired gastroenteritis
In a population of 16.5 million people the incidence of
community-acquired norovirus disease cases in The
Netherlands in 2009 was estimated to be 3800/100 000
(95% CI 2640–5440) of which 3700/100 000 (97.6%)
(95% CI 2550–5340) were estimated as seeking no
medical care, while 92/100 000 (2.4%) (95% CI
50–150) were estimated to visit a GP for their com-
plaints, and 12/100 000 (12.5%) (95% CI 5–20) were
estimated as hospitalized due to their norovirus in-
fection. The number of fatal community-acquired
cases was estimated to be 0.4/100 000 (95% CI
0.2–0.7).
Outbreaks
The number of cases involved in outbreaks in
institutions was estimated to be 30/100 000, of
which 20 (67%) were in nursing homes and 10
(33%) in hospitals. The number of fatal cases due
to norovirus outbreaks was estimated to be 0.02/
100 000.
Burden
The burden estimate calculations are shown in Tables
5 and 6. The general population incidence of noro-
virus gastroenteritis in 2009 was estimated to be 3800
cases/100 000 (95% CI 2670–5460), the number of
fatal cases 0.4/100 000 (95% CI 0.2–0.7), the number
of undiscounted DALYs 1622 (95% CI 966– 2650),
and the number of discounted DALYs 1285 (95% CI
801–1910).
Burden of foodborne disease
Community acquired
On the basis of expert opinion [26], 17% (95% CI
13–28) of norovirus illness cases can be attributed to
food, which comprises 650/100 000 (95% CI
490–1065) cases and 0.06/100 000 (95% CI 0.05–0.11)
deaths in The Netherlands in 2009, resulting in a
burden of 275 (95% CI 105–450) undiscounted and
194 (95% CI 125–320) discounted DALYs.
Table 4. Hospitalizations due to community-acquired norovirus based on GEops data (i=1, 2, 3) [18] as fractions of
the total number of hospitalizations due to gastroenteritis in general (Prismant) [17]
Age group (yr) Samples
GEops Prismant










gastroenteritis Median Mean (95% CI)
<18 96 8 6 1 8334 947 966 (541–1498)
o18 41 2 2 0 13 598 905 971 (294–2134)
GEops, GastroEnteritis Admission Study; CI, confidence interval.
Table 5. Outbreaks reported in The Netherlands, 2009 (National Institute of Public Health, The Netherlands,






per outbreak (95% CI)
Mean
life-expectancy (95% CI)
Nursing homes 75 43 0.14 (0.11–0.17) 30 months (24–40)
Hospitals 57 25 0.14 (0.11–0.17)
CI, Confidence interval.
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Outbreaks
On the basis of analysis of outbreaks reported to the
FBVE network [27] a total of 22% of all outbreaks
can be attributed to food, which comprised 6/100 000
cases and 0.01/100 000 deaths in The Netherlands in
2009, resulting in a burden of 30 undiscounted and 30
discounted DALYs.
Overall
In 2009, a total of 662/100 000 (95% CI 496–1071)
norovirus cases and 0.07/100 000 (95% CI 0.06–0.12)
deaths could be attributed to food, which comprises
305 (95% CI 135–480) undiscounted and 224 (95%
CI 155–350) discounted DALYs.
Sensitivity analysis
Community-acquired
The main parameters influencing the uncertainty of
the overall DALY estimate, either discounted or un-
discounted, were the CFR in the 12–17 years age
group and 0-year-olds, and the incidence of com-
munity-acquired norovirus gastroenteritis in the
18–64 years age group and people aged o65 years
(data not shown). The main parameters influencing
the uncertainty of deaths in community-acquired
cases were incidence of community-acquired noro-
virus gastroenteritis in people aged o65 years and,
to a much lesser extent, the incidence of overall gas-
troenteritis in this age group. In a scenario analysis,
we assumed that mortality was limited to persons that
had visited a GP, as these may be considered the more
severe cases. This resulted in a sharp decrease of
mortality to only one fatal case and of the burden to
561 DALYs. In a second scenario, we evaluated the
mortality in people aged o65 years, as described by
van Asten et al. [10] on the basis of syndromic sur-
veillance of unexplained gastroenteritis, i.e. a con-
servative estimate of 0.14 of deaths in the community
for each laboratory-reported outbreak. This resulted
in a total of 39 fatal cases in this age group, which is in
the same order of magnitude compared to the 45 fatal
cases based on the German surveillance system. In a
third sensitivity scenario, we evaluated the potential
effect of underreporting of mortality due to norovirus
in surveillance systems, and assumed 50% of under-
reporting [28]. This resulted in a sharp increase of
mortality to 119 fatal cases an increase of the burden
to 2627 DALYs.
Outbreaks
The main parameter influencing the uncertainty of the
DALY estimate, either discounted or undiscounted,
was the disability weight for persons living in nursing
homes (regression coefficient 0.93), and can be con-
sidered a data gap.
Overall
We compared three scenarios to investigate the con-
tribution of increased incidence and new insights into





General population (95% CI) (r1000) 610 (418–878) 5*
GP visit (95% CI) (r1000) 15 (9–24)
Hospitalized (95% CI) (r1000) 1.9 (1.1–3.2)
Total incidence (95% CI) (r1000) 625 (433–893) 5* 630 (438–898)
Fatal cases (95% CI) 59 (25–112 ) 3 62 (28–115)
Undiscounted burden estimates, n (95% CI)
YLD 306 (202–452) 130 (73–188) 436 (310–594)
YLL 1178 (541–2203) 8 (6–10) 1188 (548–2210)
DALYs 1486 (835–2524) 138 (80–195) 1622 (966–2650)
Discounted burden estimates, n (95% CI)
YLD 305 (200–450) 129 (72–187) 434 (308–592)
YLL 844 (388–14 674) 7 (6–9) 851 (396–1481)
DALYs 1148 (673–1796) 137 (80–194) 1285 (805–1937)
GP, General practitioner ; YLD, years lived with disability ; YLL, years of life lost ; DALYs, disability-adjusted life-years.
* Based on reported outbreaks, i.e. no uncertainty included.
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CFRs (Fig. 2) to the observed increase in the esti-
mated burden. First, the burden of norovirus in 2004
was (re)calculated using our model but without the
trend correction and using a CFR of 0.001% as de-
scribed by Mead et al. [9]. Since Mead et al. did not
provide an age stratification, 95% of the mortality
was attributed to people aged o65 years, and 5% to
people aged <65 years. Second, the burden in 2009
was calculated using trend corrections and the CFR
of Mead et al. Third, the burden was calculated using
a trend correction and CFRs based on the German
surveillance system but assuming no child mortality,
to evaluate the influence of mortality in young chil-
dren (i.e. aged <12 years). Results show that the in-
cidence increased from 3100 to 3800/100 000 between
2004 and 2009. The corresponding increase in burden
was 110 DALYs. A further increase from 900 to 1600
DALYs resulted from the new insights in mortality,
of which 200 DALYs can be attributed to mortality in
young children.
DISCUSSION
The burden of norovirus illness was estimated to be
>1600 DALYs in The Netherlands in 2009, which is
comparable to the burden of Salmonella spp. in The
Netherlands [29] which, in contrast to norovirus,
is well known as an enteric pathogen with a high
burden. The population-based age-adjusted estimates
of all norovirus cases in The Netherlands slightly in-
creased from almost 3170 cases/100 000 in 1999 on the
basis of the Sensor study [6] and 3100/100 000 in 2004
[7] to 3800 cases/100 000 in 2009 using a trend cor-
rection of 125%. However, the evidence for correc-
tion may be weak due to its indirect link to norovirus
infections as a consequence of the absence of a
case-based reporting system in The Netherlands. In
addition, an increase was observed for one level of the
reporting pyramid, i.e. hospitalizations, and there is
an implicit assumption that community cases have
also increased by the same proportion. Nevertheless,
an actual increase is likely as a result of the emergence
of new variants, as described by Siebenga et al. [13].
The updated number of 1285 estimated discounted
DALYs is higher compared to y500 in 1999 [6] and
2004 [7]. This difference is mainly attributed to the use
of a new estimate of 0.4 fatal cases/100 000 due to
norovirus. The old estimate was 5 cases/100 000 in
2004, based on the CFR reported by Mead et al. [9],
which is likely to be an underestimation. As Mead
et al. explain, the assumptions underlying the
Norwalk-like viruses figures were at that time among
the most difficult to verify, and sensitive methods for
detection were not commonly used at that time [9].
Moreover, different methods used for mortality esti-
mates complicate the inferences of a time trend, as
was also concluded by Scallan et al. [28]. Nevertheless,
higher mortality due to norovirus was found to cor-
respond with the recent increases in norovirus activity
[10], which was associated with rapidly emerging new
norovirus types of genogroup II type 4. The increases
were either due to changes in pathogenic character-
istics or a consequence of a larger number of cases
including deaths, since the population is again avail-
able as a pool of susceptible persons for each new
variant. The estimated mortality in children con-
tributed considerably to the estimated DALYs: three
fatal cases in children aged <5 years contributed 263
YLL (22% of the total YLL) resulting in an over-
all mean of 20 years of life lost per fatal case. This
finding is remarkable and indicates that mortality












ys Burden 2004 CFR mead
Burden 2009 CFR mead
Burden 2009 CFR Germany
Burden 2009 CFR Germany no child mortality
Fig. 2. [colour online]. Estimated burden in discounted and undiscounted disability-adjusted life-years (DALYs) while
comparing the effects of different assumptions. Burden 2004 : case-fatality ratio (CFR) Mead (no trend correction, CFRs as
described by Mead et al. [9]). Burden 2009 : CFRMead (trend correction, CFRs as described by Mead et al. [9]). Burden 2009 :
CFRGermany (trend correction and CFRs as reported in the German surveillance system [19]). Burden 2009 : CFRGermany
[no child mortality ; trend correction and CFRs as reported in the German surveillance system [19] but when setting child
mortality in very young children (aged <12 years) to 0].
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deceased children laboratory testing may be more
frequently performed, and thereby norovirus may be
proportionally more often recognized as the causative
agent, compared to other age groups. However, this
would underestimate CFRs in adults instead of over-
estimate CFRs in children. Several groups indicated a
likely underreporting of mortality rates due to noro-
virus for specific age groups [10, 30]. We considered
the use of a surveillance system of a country where
norovirus is notifiable to be the most direct approach
for obtaining the CFRs for all age groups. On the
basis of previous lower estimates, norovirus infection
already outnumbered by far, with respect to inci-
dence, any other foodborne pathogen [7]. Here, we
found that over 100 000 symptomatic infections and
11 deaths can be attributed to the foodborne trans-
mission of norovirus.
Since scenario analysis showed comparable results
when using mortality data from different surveillance
systems, i.e. as described by van Asten et al. [10], we
consider this as a confirmation of the robustness of
our analysis. Moreover, the CFR for outbreaks in
nursing homes based on German surveillance data is
in the same order of magnitude as the 0.03% found in
Australia [31]. In line with other burden studies, we
only partly accounted for comorbidity, which may be
considered a limitation of our study and may have
resulted in an overestimation of the burden. However,
for several reasons, we consider our estimate con-
servative. First, we consider underreporting of mor-
tality due to norovirus illness likely. Underreporting
is a common problem in surveillance systems [32],
as was also illustrated during an outbreak investi-
gation where death certificates were analysed [11],
and therefore the mortality ratios derived from
surveillance systems may be considered conservative.
Another reason is that we now assumed that every
institutional outbreak was reported, which is not
likely to be the case.
Sensitivity analysis also pointed out that the dis-
ability weight of disease in those living in a nursing
home, the incidence of norovirus gastroenteritis in
adults and the elderly, and mortality due to norovirus
in young people were the main factors influencing the
uncertainty in the burden estimates, and these may be
data gaps to be filled by future research that can
contribute to improving the burden estimates. The
uncertainty in incidences is mainly due to low num-
bers of persons in these categories in the Sensor study
[6]. Given that the Sensor study was performed over a
decade ago, the incidence of norovirus infections may
have increased since 1999 due to newly emerging
variants. For example, the studies in the UK suggest
increased incidence over a 10-year period from 12–16/
1000 to 38–55/1000 person-years. This potential in-
crease is incorporated in our estimate by using up-
dated records of hospitalizations and outbreaks.
However, if a study like Sensor is performed again it
may be advisable to include over-sampling of the
elderly and adults, so that the uncertainties in pro-
portions of pathogens can be diminished. The effect of
the disability weight of living in nursing homes can
work both ways. Either the persons living in these
institutions receive better care compared to the elderly
living at home, resulting in a lower disability weight,
or the persons that need to live in these institutions
need more care resulting in a higher disability weight.
Given that several studies were performed in nursing
homes in The Netherlands [33, 34], there should be
possibilities to investigate quality of life in nursing
homes as well as mortality during outbreaks in the
near future.
Despite the new insights in sequelae of norovirus
infection, only mortality was of influence at the
population level and is included in our calculations.
For other sequelae, like longer duration of illness
for children or hospitalized patients [35], the added
burden was estimated to be low, as it would not im-
plicate chronic effects. Benign infantile seizures [36]
are severe sequelae but have a very short duration
of several minutes and no lingering symptoms.
Encephalopathy [37] was not included because this
was only described in case reports. Although irritable
bowel syndrome was prospectively identified as a
lingering symptom of viral gastroenteritis [38], the
attribution of this disease outcome to a norovirus
infection is not yet established and needs further in-
vestigation. Similarly, the potential of chronic noro-
virus diarrhoea in immunocompromised individuals
requires confirmation before it can be included in our
estimates.
In conclusion, on the basis of newly gained insights
in the potential severe outcome of the disease, the
burden of norovirus infections overall and the conse-
quential burden of foodborne norovirus infections are
now estimated to be higher than previously assumed,
despite the fact that it is still considered a conservative
estimate. Several investigations illustrate the previous
underestimation of the burden of norovirus illness
[39], especially the foodborne proportion of norovirus
infections. Still, there are knowledge gaps in the po-
tential sequelae which need to be further investigated,
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and which may result in an even higher burden of
norovirus illness.
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